Treatment of high-grade anal intraepithelial neoplasia with infrared coagulation in a primary care population of HIV-infected men and women

Diseases of the Colon and Rectum

Volumn 55, Issue 12, 2012, Pages 1236-1243

  Weis, Stephen E ^a,b   Vecino, Isabel ^a   Pogoda, Janice M ^c   Susa, Joseph S ^d  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b Tarrant County Public Health Department   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anal dysplasia; Anal intraepithelial neoplasia; High grade anal intraepithelial neoplasia; Human immunodeficiency virus; Human papillomavirus; Infrared coagulation; Squamous cell carcinoma

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANUS CARCINOMA; ARTICLE; CANCER PATIENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RESOLUTION ANOSCOPY; HIGH RESOLUTION ENDOSCOPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIC THERAPY; INFRARED COAGULATION; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RECTUM BIOPSY; SQUAMOUS CELL CARCINOMA; THERAPY DELAY; UNITED STATES;

ADULT; ANALYSIS OF VARIANCE; ANUS DISEASES; BIOPSY; FEMALE; HIV INFECTIONS; HUMANS; LIGHT COAGULATION; MALE; PRECANCEROUS CONDITIONS; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

EID: 84872260888     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31826d5cb5     Document Type: Article

References (36)

1. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226-236.
2. Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS. 1995;9:1255-1262.
3. Kiviat N, Rompalo A, Bowden R, et al. Anal human papillomavirus infection among human immunodeficiency virus-seropositive and seronegative men. J Infect Dis. 1990;162:358-361.
4. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337:1343-1349.
5. Del Mistro A, Insacco E, Cinel A, Bonaldi L, Minucci D, Chieco-Bianchi L. Human papillomavirus infections of the genital region in human immunodeficiency virus seropositive women: integration of type 16 correlates with rapid progression. Eur J Gynaecol Oncol. 1994;15:50-58.
6. Mayaud P, Gill DK, Weiss HA, et al. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect. 2001;77:248-254.
7. Jamieson DJ, Duerr A, Burk R, et al; HIV Epidemiology Research Study (HERS) Group. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol. 2002;186:21-27.
8. Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virusinfected women in Brazil. J Clin Microbiol. 2002;40:3341-3345.
9. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIVnegative homosexual men. J Infect Dis. 1998;177:361-367.
10. Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184:682-690.
11. Egelkrout EM, Galloway D. Biology of genital human papillomaviruses. In: Holmes K, ed. Sexually Transmitted Diseases. 4th ed. New York, NY: McGraw-Hill; 2008:463-488.
12. Khanna N, Brooks SE, Chen TT, Simsir A, Gordon NJ, Taylor G. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal Papanicolaou smears: a study of a university-based inner city population. J Hum Virol. 2001;4:283-287.
13. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265.
14. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
15. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes, Screening for squamous cervical cancer: duration of low risk after negative results of cytology and its implication for screening policies. BMJ 1986;293:659-664.
16. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337:1350-1358.
17. Zbar AP, Fenger C, Efron J, Beer-Gabel M, Wexner SD. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis. 2002;17:203-215.
18. Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg. 2006;76:715-717.
19. D'Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2008;48:491-499.
20. New York State Department of Health AIDS Institute. Neoplastic Complications Of HIV Infection V. Anal Dysplasia and Cancer. Available at: www.hivguidelines.org. Accessed April 23, 2010.
21. Shalev N, Olender SA, Chiasson MA. Targeted anal cancer screening in HIV-infected patients: prevalence of screening indicators. AIDS. 2010;24:1086-1087.
22. Goldstone SE, Kawalek AZ, Huyett JW. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum. 2005;48:1042-1054.
23. Chin-Hong PV, Palefsky JM. Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther. 2005;18:67-76.
24. Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. Highresolution anoscopy targeted surgical destruction of anal highgrade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum. 2008;51:829-835.
25. Stier EA, Goldstone SE, Berry JM, et al. Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr. 2008;47:56-61.
26. Cranston RD, Hirschowitz SL, Cortina G, Moe AA. A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men. Int J STD AIDS. 2008;19: 118-120.
27. Goldstone RN, Goldstone AB, Russ J, Goldstone SE. Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men. Dis Colon Rectum. 2011;54:1284-1292.
28. Weis SE, Vecino I, Pogoda JM, et al. Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum. 2011;54: 433-441.
29. Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum. 1997;40:919-928.
30. Adair C. Pathology of the anus. In: Iacobuzio-Donahue CA, Montgomery E, Goldblum JR, eds. Gastrointestinal and Liver Pathology. New York, NY: Churchill Livingstone; 2005:395-438.
31. Wieland U, Brockmeyer NH, Weissenborn SJ, et al. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol. 2006;142:1438-1444.
32. Brown SR, Skinner P, Tidy J, Smith JH, Sharp F, Hosie KB. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen's disease). Br J Surg. 1999;86:1063-1066.
33. Devaraj B, Cosman BC. Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum. 2006;49:36-40.
34. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer. 2004;101:281-288.
35. Piketty C, Selinger-Leneman H, Grabar S, et al; FHDH-ANRS CO 4. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008;22:1203-1211.
36. Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg. 2005;92:1133-1136.